Recent Articles from GlobeNewswire

From Swan Lake to The Nutcracker, ballet star shares the reality of living and dancing with hearing loss

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today reported financial results for the third quarter of 2025. Additional operating results and management commentary can be found in the Company’s shareholder letter, which is posted to its investor relations website at investors.fiverr.com.

Pratteln, Switzerland, November 5, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, to support the global launches of AGAMREE® (vamorolone).

ISS, a leading global workplace experience and facility services company, has extended and expanded its partnership with key Australian customer Brisbane Airport through a new contract that includes additional aviation security services. The new contract, commencing November 2025, has a five-year duration with options for a further three years.

Melville, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the launch of the CR-N400 and CR-N350, two new Pan-Tilt-Zoom (PTZ) cameras designed to deliver outstanding image quality, versatile connectivity, and advanced control for professional video applications. These cameras cater to an array of studio productions, live events, houses of worship, corporate settings, and educational environments, offering a powerful combination of features at a competitive price point.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against WPP plc (NYSE: WPP), if they purchased or otherwise acquired the Company’s shares between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX), if they purchased or otherwise acquired the Company’s shares between May 20, 2025, and August 18, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Marex Group plc (“Marex” or the “Company”) (NasdaqGS: MRX), if they purchased or otherwise acquired the Company’s securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH), if they purchased or otherwise acquired the Company’s securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

NEW YORK CITY and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 30, 2025 to file lead plaintiff applications in a securities class action lawsuit against Synopsys, Inc. (“Synopsys” or the “Company”) (NasdaqGS: SNPS), if they purchased or otherwise acquired the Company’s securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against KBR, Inc. (NYSE: KBR), if they purchased or otherwise acquired the Company’s securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Texas.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Fluor Corporation (NYSE: FLR), if they purchased or otherwise acquired the Company’s securities between February 18, 2025 and July 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Texas.

NEW YORK and NEW ORLEANS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against V.F. Corporation. (NYSE: VFC), if they purchased or otherwise acquired VFC securities between October 30, 2023 and May 20, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.

Free-to-Enter Program Recognizes Innovation in Education Technology Worldwide

Springdale, AR, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Anderson Air, a long-established HVAC company based in Springdale, is marking more than five decades of service to Northwest Arkansas. Since opening in 1967, the company has provided residential and commercial heating, ventilation, and air conditioning services to communities across the region, including Fayetteville, Bentonville, Rogers, and surrounding areas.

Casper, WY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- With research showing that up to 60% of individuals carry MTHFR gene variants that may reduce the body’s ability to convert folic acid into active folate, Neupril introduces a clinically active L-Methylfolate formula designed to help address this nutritional challenge. The formulation provides a bioavailable form of folate that the body can utilize directly, supporting pathways related to mood, energy, and cognitive health. Neupril’s approach combines evidence-based formulation practices with a focus on integrity, transparency, and public education in the supplement industry.

Press ReleaseNokia extends SoftBank Corp. partnership with network modernization deal in Japan

Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosing

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ:BYND). The investigation concerns whether the Company may have violated federal securities laws or engaged in other unlawful business practices.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO). The investigation concerns whether the Company may have violated federal securities laws or engaged in other unlawful business practices.

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the completion of patient enrollment of SAFFRON, a global Phase III study of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) for the treatment of patients with epidermal growth factor receptor (“EGFR”)-mutated, MET-overexpressed and/or amplified, locally advanced or metastatic non-small cell lung cancer (“NSCLC”) following progression on treatment with TAGRISSO®. The last patient was randomized on October 31, 2025.

EAGLE, Idaho, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces two significant acquisitions that strengthen its presences in key markets.

ROAD TOWN, British Virgin Islands, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has filed its audited consolidated financial statements and earnings release (together, “Financial and Operational Results”) for the period ended September 30, 2025. The full version of the Financial and Operational Results can be viewed on the Company’s website at www.auraminerals.com, on SEDAR+ at www.sedarplus.ca. or on SEC www.sec.com.

ROAD TOWN, British Virgin Islands, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (Nasdaq: AUGO) (B3: AURA33) (“Aura” or the “Company”) announced today that the Company’s Board of Directors (the “Board”) has declared and approved the payment of a dividend (the “Dividend”) of US$0.48 per common share (approximately US$ 40.1 2 million in total). This payment is above the minimum foreseen in the Company’s Dividend Policy (the “Dividend Policy”). Under the Dividend Policy, the Company may determine quarterly cash dividends in an aggregate amount equal to 20% of its reported Adjusted EBITDA3 for the relevant three months, less sustaining capital expenditures and exploration capital expenditures for the same period.

Smirk & Dagger Games, B. Stuyvesant Champagne, LLC, Leo D. Bernstein & Sons Inc. d/b/a Bernstein Display v. President Donald J. Trump, et al.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE:JHX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fiserv (FI) To Contact Him Directly To Discuss Their Options

COLUMBUS, Wis., Nov. 04, 2025 (GLOBE NEWSWIRE) -- In light of recent market developments, Michael Eisenga, CEO of First American Properties, felt compelled to issue a statement on his observations and concerns regarding liquidity conditions, central-bank policy shifts, and the implications for the housing market and broader economy.

      DALLAS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) mourns the passing of C.W. “Bill” Russell, a dedicated member of our Board of Managers and Advisory Committee since 2004, and Chairman of the Audit Committee.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. (NASDAQ:ATYR), Marex Group PLC (NASDAQ:MRX), Cepton, Inc. (NASDAQ:CPTN), and MoonLake Immunotherapeutics (NASDAQ:MLTX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Baxter International, Inc. (NYSE:BAX), Spirit Aviation Holdings, Inc. (OTCMKTS:FLYYQ), and Molina Healthcare, Inc. (NYSE: MOH). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fly-E (FLYE)To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Savara (SVRA) To Contact Him Directly To Discuss Their Options

MONTREAL, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Air Canada today reported its third quarter 2025 financial results.

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) --

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced the appointment of Andrew Scott as Vice President of Corporate Communications. In this new role, Mr. Scott will oversee investor relations, capital markets strategy, and corporate communications, while supporting the Company’s licensing and partnership initiatives.

New quarterly records for net income, EBITDA, net cash from operating activities and free cash flow1

(all amounts in US dollars, unless otherwise noted)

TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX : MRE) today announced it will report its financial results for the third quarter ended September 30, 2025 on Tuesday, November 11, 2025 after the markets close, and will hold a conference call to discuss the results the same day at 5:30 p.m. Eastern Time. To participate, please dial 416-855-9085 (Toronto area) or 800-990-2777 (toll free Canada and US) and enter conference ID – 53112#. Please call 10 minutes prior to the start of the conference call.

 

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) --

Record free cash flow of approximately $700 million and achieved net cash position Increased 2025 share buyback target by 20% to $600 million and dividend by 17%On track to meet annual guidance

TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC”, together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce its third-quarter 2025 consolidated financial results and operational highlights. All financial references are denominated in U.S. dollars, unless otherwise noted.

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.)

Robust Quarterly Organic Revenue Growth of 7.0%,with an Expansion in Quarter-Over-Quarter Gross Profit Margin of 300 Basis Points,Generating Net Income of $13.1 million and Earnings Per Diluted Share of $0.41, Achieving Record Adjusted EBITDA of $30.2 million

Continued strength in Fuel Specialties offsetting lower than expected results in our other business segments

Frisco, TX, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligned for Impact: Wisdom From Today’s Purpose-Driven Leaders, co-authored by Nick and Megan Unsworth, founders of the coaching movement Life on Fire, has reached #1 Amazon Bestseller status in six categories within days of its release. These include Personal Transformation & Spirituality, Spiritual Self-Help, and Spiritual Healing categories, signaling a resonance with readers seeking wisdom, courage, and actionable inspiration.

Most Common Commercial Kitchen Cutting Surfaces Shed Plastic Dandruff into Food

Raised Quarterly Dividend by 5%

Expands Power-To-CCS Story: Signs Carbon Management MOU with Capital Power for Up to 3 Million Metric Tons Per Annum of CO2 Emissions

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in November:

Châtillon, France, November 4, 2025

SINGAPORE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that it will release its third quarter financial results for the quarter ended September 30, 2025, before the U.S. market open on November 12, 2025.

GREENWICH, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the third quarter 2025.

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to five new employees to purchase an aggregate of 148,600 shares of the Company's common stock, effective as of November 3, 2025. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

CRC’s Carbon TerraVault and Capital Power Sign MOU to Explore Transportation and Sequestration of up to 3 Million Metric Tons of CO2 Emissions Per Year

The 29th Annual Urbanworld Film Festival honored winners representing 16 countries including the United States, South Korea, the United Kingdom, France, China, and several across the African continent. Moviegoers celebrated visionary voices and groundbreaking storytelling, setting the stage for a monumental 30th anniversary celebration next year in New York City.

PERRYSBURG, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE             

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the third quarter ended September 30, 2025, and provided a business update.

SANTA CLARA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the third quarter of 2025. Third quarter revenue was a record $9.2 billion, gross margin was 52%, operating income was $1.3 billion, net income was $1.2 billion and diluted earnings per share was $0.75. On a non-GAAP(*) basis, gross margin was 54%, operating income was $2.2 billion, net income was $2 billion and diluted earnings per share was $1.20. Our third quarter results did not include any revenue from shipments of AMD Instinct™ MI308 GPU products to China.

SANTA MONICA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its Third Quarter 2025 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com.

SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Whitestone REIT (NYSE: WSR), a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has received an unsolicited, non-binding proposal from MCB Real Estate to acquire all of the outstanding shares of the Company’s common stock for cash consideration of $15.20 per share. MCB Real Estate owns 9.2% of Whitestone REIT’s common stock.

DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its third quarter financial results and a letter to shareholders from CEO, Jeffrey Kip on the investor relations section of its website at ir.angi.com/quarterly-earnings. As announced previously, Angi Inc. will host a conference call to discuss the company’s third quarter results and to answer questions. The call will be held on Wednesday, November 5, 2025, at 8:30 a.m. ET. Jeffrey Kip, CEO and Andrew Russakoff, CFO will participate.

Net Income of $5.8 Million and Diluted EPS of $0.51 Per Share 

CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance.

- Increased 2025 AFFO Guidance $0.06 to $1.30 - $1.32 Per Diluted Share -- Amended, Extended, and Expanded Unsecured Credit Facilities to $440 Million -- U.S. Postal Service Operations Not Affected by Government Shutdown -- Acquired 47 USPS Properties for $42.3 million at a Weighted Average Capitalization Rate of 7.7% -- Raised $26.0 Million from ATM Program During Q3 to Fund Acquisitions -

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year

SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the third quarter of fiscal year 2025, ended September 30, 2025.

Over 3 million Paid Subscribers, up 6% over Q3 2024